123 related articles for article (PubMed ID: 10976520)
1. Nicorandil analogues containing NO-donor furoxans and related furazans.
Boschi D; Cena C; Di Stilo A; Fruttero R; Gasco A
Bioorg Med Chem; 2000 Jul; 8(7):1727-32. PubMed ID: 10976520
[TBL] [Abstract][Full Text] [Related]
2. New 1,4-dihydropyridines conjugated to furoxanyl moieties, endowed with both nitric oxide-like and calcium channel antagonist vasodilator activities.
Di Stilo A; Visentin S; Cena C; Gasco AM; Ermondi G; Gasco A
J Med Chem; 1998 Dec; 41(27):5393-401. PubMed ID: 9876109
[TBL] [Abstract][Full Text] [Related]
3. Nitric oxide donor beta2-agonists: furoxan derivatives containing the fenoterol moiety and related furazans.
Buonsanti MF; Bertinaria M; Stilo AD; Cena C; Fruttero R; Gasco A
J Med Chem; 2007 Oct; 50(20):5003-11. PubMed ID: 17845020
[TBL] [Abstract][Full Text] [Related]
4. Study of synthesis and cardiovascular activity of some furoxan derivatives as potential NO-donors.
Mu L; Feng SS; Go ML
Chem Pharm Bull (Tokyo); 2000 Jun; 48(6):808-16. PubMed ID: 10866141
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and vasodilating properties of N-alkylamide derivatives of 4-amino-3-furoxancarboxylic acid and related azo derivatives.
Ovchinnikov IV; Kulikov AS; Makhova NN; Tosco P; Di Stilo A; Fruttero R; Gasco A
Farmaco; 2003 Sep; 58(9):677-81. PubMed ID: 13679160
[TBL] [Abstract][Full Text] [Related]
6. Guanylate cyclase and not ATP-dependent K(+) channels seems temperature-dependent in smooth muscle relaxation of human umbilical arteries.
Tiritilli A
Eur J Pharmacol; 2000 Oct; 406(1):79-84. PubMed ID: 11011037
[TBL] [Abstract][Full Text] [Related]
7. New 1,4-dihydropyridines endowed with NO-donor and calcium channel agonist properties.
Visentin S; Rolando B; Di Stilo A; Fruttero R; Novara M; Carbone E; Roussel C; Vanthuyne N; Gasco A
J Med Chem; 2004 May; 47(10):2688-93. PubMed ID: 15115410
[TBL] [Abstract][Full Text] [Related]
8. Second generation of alpha-tocopherol analogs-nitric oxide donors: Synthesis, physicochemical, and biological characterization.
López GV; Blanco F; Hernández P; Ferreira A; Piro OE; Batthyány C; González M; Rubbo H; Cerecetto H
Bioorg Med Chem; 2007 Sep; 15(18):6262-72. PubMed ID: 17627828
[TBL] [Abstract][Full Text] [Related]
9. The furoxan system: design of selective nitric oxide (NO) donor inhibitors of COX-2 endowed with anti-aggregatory and vasodilating activities.
Del Grosso E; Boschi D; Lazzarato L; Cena C; Di Stilo A; Fruttero R; Moro S; Gasco A
Chem Biodivers; 2005 Jul; 2(7):886-900. PubMed ID: 17193179
[TBL] [Abstract][Full Text] [Related]
10. Dual mechanism of action of nicorandil on rabbit corpus cavernosal smooth muscle tone.
Hsieh GC; Kolasa T; Sullivan JP; Brioni JD
Int J Impot Res; 2001 Aug; 13(4):240-6. PubMed ID: 11494082
[TBL] [Abstract][Full Text] [Related]
11. Functional contribution of the endothelial component to the vasorelaxing effect of resveratrol and NS 1619, activators of the large-conductance calcium-activated potassium channels.
Calderone V; Martelli A; Testai L; Martinotti E; Breschi MC
Naunyn Schmiedebergs Arch Pharmacol; 2007 Mar; 375(1):73-80. PubMed ID: 17203288
[TBL] [Abstract][Full Text] [Related]
12. A xanthine-based KMUP-1 with cyclic GMP enhancing and K(+) channels opening activities in rat aortic smooth muscle.
Wu BN; Lin RJ; Lin CY; Shen KP; Chiang LC; Chen IJ
Br J Pharmacol; 2001 Sep; 134(2):265-74. PubMed ID: 11564644
[TBL] [Abstract][Full Text] [Related]
13. Studies on agents with mixed NO-dependent and calcium channel antagonistic vasodilating activities.
Cena C; Visentin S; Di Stilo A; Boschi D; Fruttero R; Gasco A
Pharm Res; 2001 Feb; 18(2):157-65. PubMed ID: 11405285
[TBL] [Abstract][Full Text] [Related]
14. A new class of furoxan derivatives as NO donors: mechanism of action and biological activity.
Ferioli R; Folco GC; Ferretti C; Gasco AM; Medana C; Fruttero R; Civelli M; Gasco A
Br J Pharmacol; 1995 Feb; 114(4):816-20. PubMed ID: 7773542
[TBL] [Abstract][Full Text] [Related]
15. Vasodilatation of canine cerebral arteries by nicorandil, pinacidil and lemakalim.
Zhang H; Stockbridge N; Weir B; Vollrath B; Cook D
Gen Pharmacol; 1992 Mar; 23(2):197-201. PubMed ID: 1353469
[TBL] [Abstract][Full Text] [Related]
16. The relaxation induced by S-nitroso-glutathione and S-nitroso-N-acetylcysteine in rat aorta is not related to nitric oxide production.
Ceron PI; Cremonez DC; Bendhack LM; Tedesco AC
J Pharmacol Exp Ther; 2001 Aug; 298(2):686-94. PubMed ID: 11454932
[TBL] [Abstract][Full Text] [Related]
17. NO-donor phenols: a new class of products endowed with antioxidant and vasodilator properties.
Boschi D; Tron GC; Lazzarato L; Chegaev K; Cena C; Di Stilo A; Giorgis M; Bertinaria M; Fruttero R; Gasco A
J Med Chem; 2006 May; 49(10):2886-97. PubMed ID: 16686532
[TBL] [Abstract][Full Text] [Related]
18. Studies on agents with mixed NO-dependent vasodilating and beta-blocking activities.
Boschi D; Di Stilo A; Cena C; Lolli M; Fruttero R; Gasco A
Pharm Res; 1997 Dec; 14(12):1750-8. PubMed ID: 9453064
[TBL] [Abstract][Full Text] [Related]
19. Characterisation of furoxancarbonitriles as a new class of vasodilators.
Gasco AM; Boschi D; Di Stilo A; Medana C; Gasco A; Martorana PA; Schönafinger K
Arzneimittelforschung; 1998 Mar; 48(3):212-8. PubMed ID: 9553676
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological activity of novel 2-(alpha-alkoxyimino)benzylpyridine derivatives as K+ channel openers.
Maekawa T; Yamamoto S; Igata Y; Ikeda S; Watanabe T; Shiraishi M
Chem Pharm Bull (Tokyo); 1997 Dec; 45(12):1994-2004. PubMed ID: 9433769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
